Method for delivery of smooth muscle cell inhibitors
US5171217A · kind A · utility
324Cited by
10References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 28, 1991 |
| Grant date | Dec 15, 1992 |
| Priority date | — |
| Expiry date | Feb 28, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/1647
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method and composition for delivering a drug to an affected intramural site for sustained release in conjunction with or following balloon catheter procedures, such as angioplasty. The drug, carried by microparticles of a physiologically-compatible, biodegradable polymer is injected under directed pressure into the wall of a body vessel in the region of the affected site.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.